Back
Marinus Pharmaceuticals Vs. Affirm Holdings Industry Stock Comparison
Sell
34
MRNS
Marinus Pharmaceuticals
Last Price:
1.42
Seasonality Move:
5.37%
Sell
39
AFRM
Affirm Holdings
Last Price:
29.29
Seasonality Move:
6.32%
Sell
34
Marinus Pharmaceuticals (MRNS)
is a Sell
Is Marinus Pharmaceuticals a Buy, Sell or Hold?
- The current Marinus Pharmaceuticals [MRNS] share price is $1.42. The Score for MRNS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- MRNS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Affirm Holdings (AFRM)
is a Sell
Is Affirm Holdings a Buy, Sell or Hold?
- The current Affirm Holdings [AFRM] share price is $29.27. The Score for AFRM is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- AFRM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRNS Stock Price Chart
What is Marinus Pharmaceuticals's stock price today?
-
The Marinus Pharmaceuticals share price today is $1.42
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRNS is experiencing selling pressure, which indicates risk of future bearish movement.
AFRM Stock Price Chart
What is Affirm Holdings's stock price today?
-
The Affirm Holdings share price today is $29.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AFRM is experiencing slight selling pressure.
MRNS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.5 | Sell |
| Relative Strength Index (14 RSI): | 28.75 | Sell |
| Chaikin Money Flow: | -690539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.32 - 1.48) | Buy |
| Bollinger Bands (100): | (2.85 - 10.55) | Sell |
AFRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 41.06 | Sell |
| Chaikin Money Flow: | -616612 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.19 - 34.17) | Sell |
| Bollinger Bands (100): | (31.95 - 40.83) | Sell |
MRNS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.4 | Buy |
| 20-day SMA: | 1.4 | Buy |
| 50-day SMA: | 3.68 | Sell |
| 200-day SMA: | 7.11 | Sell |
| 8-day EMA: | 1.42 | Sell |
| 20-day EMA: | 1.64 | Sell |
| 50-day EMA: | 3.34 | Sell |
| 200-day EMA: | 6.5 | Sell |
AFRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.95 | Sell |
| 20-day SMA: | 31.97 | Sell |
| 50-day SMA: | 32.93 | Sell |
| 200-day SMA: | 31.61 | Sell |
| 8-day EMA: | 30 | Sell |
| 20-day EMA: | 31.24 | Sell |
| 50-day EMA: | 32.95 | Sell |
| 200-day EMA: | 31.5 | Sell |
Marinus Pharmaceuticals Earnings Growth & MRNS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, an increase next quarter of $0.23 per share, an increase this year of $0.56 per share, and an increase next year of $0.84 per share.
Affirm Holdings Earnings Growth & AFRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.08 per share, an increase this year of $1.10 per share, and a decrease next year of $0.00 per share.
Marinus Pharmaceuticals Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Affirm Holdings Technical Analysis
| May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | May 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||